Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adial Pharmaceuticals, Inc - Common Stock (NQ:ADIL)

0.6749 +0.0149 (+2.26%)
Streaming Delayed Price Updated: 9:56 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,713
Open 0.6700
Bid (Size) 0.6600 (93)
Ask (Size) 0.6750 (25)
Prev. Close 0.6600
Today's Range 0.6600 - 0.6750
52wk Range 0.5704 - 3.000
Shares Outstanding 20,298,156
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: Adial Pharmaceuticals Secures FDA End of Phase 2 Meeting Request To Discuss Upcoming Clinical Development Plan For Lead Program
FDA schedules End of Phase 2 meeting with Adial to discuss Phase 3 plans for AD04, its genetically targeted drug for Alcohol Use Disorder. 
Via Benzinga
Exposures Product Safety
Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-36.4%
-36.4%
1 Month
+3.8%
+3.8%
3 Month
-14.6%
-14.6%
6 Month
-33.2%
-33.2%
1 Year
-55.0%
-55.0%

More News

Read More
Retail Traders Flock To Adial Pharma After Patent News Sends Shares Soaring
Via Stocktwits
Topics Intellectual Property Stocks
Exposures Intellectual Property US Equities
Get insights into the top gainers and losers of Thursday's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EXCLUSIVE: Adial Pharmaceuticals Expands Patent Portfolio With New US Patent For Lead Drug For Alcohol And Opioid Use Disorders
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
EXCLUSIVE: After FDA Response, Adial Starts Manufacturing Clinical Supplies For Upcoming Phase 3 Program Of Lead Candidate For Alcohol Use Disorder
Via Benzinga
Exposures Product Safety
EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
EXCLUSIVE: Adial Pharmaceuticals Reveals Positive Pharmacokinetics Study Results Of AD04 For Alcohol Use Disorder
Via Benzinga
EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
Via Benzinga
Exposures Product Safety
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
ADIL Stock Earnings: Adial Pharmaceuticals Reported Results for Q2 2024
Via InvestorPlace
EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder
Via Benzinga
EXCLUSIVE: Adial Pharmaceuticals' Last Patient Dosed in Pharmacokinetics Study of AD04 For Alcohol Use Disorder, Data Expected In Q4
Via Benzinga
Gold Moves Higher; Coca-Cola Increases FY24 Forecast
Via Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Is Serve Robotics (SERV) Stock Down Today?
Via InvestorPlace
Why Is Jaguar Health (JAGX) Stock Down 55% Today?
Via InvestorPlace
Crude Oil Down 2%; GE Aerospace Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Why Is Adial Pharmaceuticals (ADIL) Up 61% Today?
Via InvestorPlace

Frequently Asked Questions

Is Adial Pharmaceuticals, Inc - Common Stock publicly traded?
Yes, Adial Pharmaceuticals, Inc - Common Stock is publicly traded.
What exchange does Adial Pharmaceuticals, Inc - Common Stock trade on?
Adial Pharmaceuticals, Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adial Pharmaceuticals, Inc - Common Stock?
The ticker symbol for Adial Pharmaceuticals, Inc - Common Stock is ADIL on the Nasdaq Stock Market
What is the current price of Adial Pharmaceuticals, Inc - Common Stock?
The current price of Adial Pharmaceuticals, Inc - Common Stock is 0.6749
When was Adial Pharmaceuticals, Inc - Common Stock last traded?
The last trade of Adial Pharmaceuticals, Inc - Common Stock was at 05/19/25 09:56 AM ET
What is the market capitalization of Adial Pharmaceuticals, Inc - Common Stock?
The market capitalization of Adial Pharmaceuticals, Inc - Common Stock is 13.70M
How many shares of Adial Pharmaceuticals, Inc - Common Stock are outstanding?
Adial Pharmaceuticals, Inc - Common Stock has 14M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.